J Biol Eng. 2017 Mar 01;11:10. doi: 10.1186/s13036-017-0052-9. eCollection 2017.
Technical advances in global DNA methylation analysis in human cancers.
Journal of biological engineering
Basudev Chowdhury, Il-Hoon Cho, Joseph Irudayaraj
Affiliations
Affiliations
- Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, 47907 IN USA.
- Department of Biomedical Laboratory Science, College of Health Science, Eulji University, Seongnam, 461-713 Republic of Korea.
- Bindley Bioscience Center, Purdue University, West Lafayette, IN 47907 USA.
PMID: 28261325
PMCID: PMC5331624 DOI: 10.1186/s13036-017-0052-9
Abstract
Prototypical abnormalities of genome-wide DNA methylation constitute the most widely investigated epigenetic mechanism in human cancers. Errors in the cellular machinery to faithfully replicate the global 5-methylcytosine (5mC) patterns, commonly observed during tumorigenesis, give rise to misregulated biological pathways beneficial to the rapidly propagating tumor mass but deleterious to the healthy tissues of the affected individual. A growing body of evidence suggests that the global DNA methylation levels could serve as utilitarian biomarkers in certain cancer types. Important breakthroughs in the recent years have uncovered further oxidized derivatives of 5mC - 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC), thereby expanding our understanding of the DNA methylation dynamics. While the biological roles of these epigenetic derivatives are being extensively characterized, this review presents a perspective on the opportunity of innovation in the global methylation analysis platforms. While multiple methods for global analysis of 5mC in clinical samples exist and have been reviewed elsewhere, two of the established methods - Liquid Chromatography coupled with mass spectrometry (LC-MS/MS) and Immunoquantification have successfully evolved to include the quantitation of 5hmC, 5fC and 5caC. Although the analytical performance of LC-MS/MS is superior, the simplicity afforded by the experimental procedure of immunoquantitation ensures it's near ubiquity in clinical applications. Recent developments in spectroscopy, nanotechnology and sequencing also provide immense promise for future evaluations and are discussed briefly. Finally, we provide a perspective on the current scenario of global DNA methylation analysis tools and present suggestions to develop the next generation toolset.
Keywords: 5-carboxylcytosine (5caC); 5-formylcytosine (5fC); 5-hydroxymethylcytosine (5hmC); 5-methylcytosine (5mC); Immunoquantitation; LC-MS/MS; Next generation toolset
References
- J Natl Cancer Inst. 2000 Apr 5;92(7):564-9 - PubMed
- Biotech Histochem. 2000 Nov;75(6):251-8 - PubMed
- J Chromatogr B Biomed Sci Appl. 2001 May 5;755(1-2):185-94 - PubMed
- Methods. 2002 Jun;27(2):156-61 - PubMed
- Oncogene. 2002 Aug 12;21(35):5400-13 - PubMed
- Curr Biol. 2002 Aug 20;12(16):1360-7 - PubMed
- Nat Rev Genet. 2002 Nov;3(11):889-95 - PubMed
- Symp Soc Exp Biol. 1958;12:138-63 - PubMed
- Nucleic Acids Res. 2004 Feb 18;32(3):e38 - PubMed
- Anal Chem. 2005 Jan 15;77(2):504-10 - PubMed
- Dev Biol. 2005 Feb 15;278(2):274-88 - PubMed
- Nat Rev Genet. 2005 Aug;6(8):597-610 - PubMed
- Nat Clin Pract Oncol. 2005 Dec;2 Suppl 1:S4-11 - PubMed
- Exp Cell Res. 2006 Jul 1;312(11):1989-95 - PubMed
- Cancer Res. 2006 Sep 1;66(17):8462-9468 - PubMed
- Nat Cell Biol. 2007 Jan;9(1):2-6 - PubMed
- Cell. 2007 Feb 23;128(4):635-8 - PubMed
- Clin Chem Lab Med. 2007;45(7):903-11 - PubMed
- J Biol Chem. 1948 Aug;175(1):315-32 - PubMed
- Science. 2009 May 15;324(5929):930-5 - PubMed
- Science. 2009 May 15;324(5929):929-30 - PubMed
- PLoS One. 2010 Jan 26;5(1):e8888 - PubMed
- Nat Rev Genet. 2010 Mar;11(3):204-20 - PubMed
- Anal Chem. 2010 Mar 15;82(6):2480-7 - PubMed
- Epigenetics. 2010 Apr;5(3):206-13 - PubMed
- Epigenomics. 2009 Dec;1(2):239-59 - PubMed
- Nat Protoc. 2010 Jul;5(7):1255-64 - PubMed
- Adv Genet. 2010;70:27-56 - PubMed
- Nature. 2010 Dec 9;468(7325):839-43 - PubMed
- Anal Chem. 2010 Dec 1;82(23):9901-8 - PubMed
- Anal Biochem. 2011 May 15;412(2):203-9 - PubMed
- Nature. 2011 May 19;473(7347):394-7 - PubMed
- Urol Oncol. 2013 Jul;31(5):628-34 - PubMed
- J Nucleic Acids. 2011;2011:870726 - PubMed
- Science. 2011 Sep 2;333(6047):1300-3 - PubMed
- Oncotarget. 2011 Aug;2(8):627-37 - PubMed
- Nat Rev Cancer. 2011 Sep 23;11(10):726-34 - PubMed
- Cancer Res. 2011 Dec 15;71(24):7360-5 - PubMed
- Anal Biochem. 2012 Mar 15;422(2):74-8 - PubMed
- Int J Cancer. 2012 Oct 1;131(7):1577-90 - PubMed
- Anal Chem. 2012 Feb 21;84(4):1799-803 - PubMed
- Oncogene. 2013 Jan 31;32(5):663-9 - PubMed
- J Cell Sci. 2012 Jun 15;125(Pt 12):2954-64 - PubMed
- Analyst. 2012 May 7;137(9):2032-5 - PubMed
- PLoS One. 2012;7(7):e41036 - PubMed
- Anal Chem. 2012 Oct 16;84(20):8602-6 - PubMed
- BMC Biol. 2013 Jan 22;11:4 - PubMed
- Clin Chem. 2013 May;59(5):824-32 - PubMed
- Biosens Bioelectron. 2013 Jul 15;45:34-9 - PubMed
- Head Neck. 2014 Mar;36(3):419-24 - PubMed
- Br J Cancer. 2013 Jul 23;109(2):408-15 - PubMed
- Epigenetics. 2013 Oct;8(10):1089-100 - PubMed
- PLoS One. 2013 Nov 18;8(11):e79044 - PubMed
- Anal Chem. 2014 Jan 7;86(1):346-50 - PubMed
- Cold Spring Harb Perspect Biol. 2014 Jan 01;6(1):null - PubMed
- Br J Cancer. 2014 May 27;110(11):2765-71 - PubMed
- Cold Spring Harb Perspect Biol. 2014 May 01;6(5):a019133 - PubMed
- Lab Chip. 2014 Jul 7;14(13):2354-62 - PubMed
- Blood. 2014 Aug 14;124(7):1110-8 - PubMed
- PLoS One. 2014 Sep 03;9(9):e106290 - PubMed
- Biosens Bioelectron. 2015 May 15;67:443-9 - PubMed
- Ann Surg Oncol. 2015 Apr;22(4):1280-7 - PubMed
- Anal Chim Acta. 2014 Dec 10;852:212-7 - PubMed
- Genome Med. 2014 Aug 30;6(8):66 - PubMed
- Anal Chem. 2015 Feb 3;87(3):1846-52 - PubMed
- Anal Chem. 2015 Mar 17;87(6):3445-52 - PubMed
- Nucleic Acids Res. 2015 Mar 31;43(6):3046-55 - PubMed
- Biosens Bioelectron. 2015 Aug 15;70:366-71 - PubMed
- Sci Rep. 2015 Apr 22;5:9281 - PubMed
- Tumour Biol. 2015 Nov;36(11):8439-46 - PubMed
- Biosens Bioelectron. 2015 Nov 15;73:228-233 - PubMed
- J Phys Chem Lett. 2014 Aug 7;5(15):2601-7 - PubMed
- Clin Epigenetics. 2015 Aug 21;7:88 - PubMed
- Angew Chem Int Ed Engl. 2015 Nov 9;54(46):13650-4 - PubMed
- Anal Chem. 2015 Nov 17;87(22):11581-6 - PubMed
- ACS Nano. 2015 Dec 22;9(12):11924-32 - PubMed
- J Oral Pathol Med. 2016 Jul;45(6):409-17 - PubMed
- J Chromatogr A. 2015 Dec 24;1426:64-8 - PubMed
- Clin Cancer Res. 2016 Apr 15;22(8):2074-82 - PubMed
- Cell Res. 2016 Jan;26(1):103-18 - PubMed
- PLoS One. 2016 Jan 19;11(1):e0146302 - PubMed
- PLoS One. 2016 Jan 28;11(1):e0147514 - PubMed
- Oncotarget. 2016 Apr 5;7(14):18787-97 - PubMed
- Anal Chem. 2016 Apr 5;88(7):3476-80 - PubMed
- Clin Epigenetics. 2016 Mar 12;8:31 - PubMed
- Chem Commun (Camb). 2016 Apr 7;52(27):4930-3 - PubMed
- Saudi J Gastroenterol. 2016 Mar-Apr;22(2):139-47 - PubMed
- PLoS One. 2016 Apr 06;11(4):e0153100 - PubMed
- Biosens Bioelectron. 2017 Jun 15;92:755-762 - PubMed
- J Chromatogr. 1988 Oct 28;452:51-60 - PubMed
- Chem Sci. 2015 Oct 1;6(10):5628-5634 - PubMed
- Nature. 1983 Jan 6;301(5895):89-92 - PubMed
- Nucleic Acids Res. 1983 Oct 11;11(19):6883-94 - PubMed
Publication Types